Correlation Between Genfit and INGERSOLL
Specify exactly 2 symbols:
By analyzing existing cross correlation between Genfit and INGERSOLL RAND LUXEMBOURG FIN, you can compare the effects of market volatilities on Genfit and INGERSOLL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Genfit with a short position of INGERSOLL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Genfit and INGERSOLL.
Diversification Opportunities for Genfit and INGERSOLL
Very good diversification
The 3 months correlation between Genfit and INGERSOLL is -0.23. Overlapping area represents the amount of risk that can be diversified away by holding Genfit and INGERSOLL RAND LUXEMBOURG FIN in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on INGERSOLL RAND LUXEM and Genfit is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Genfit are associated (or correlated) with INGERSOLL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of INGERSOLL RAND LUXEM has no effect on the direction of Genfit i.e., Genfit and INGERSOLL go up and down completely randomly.
Pair Corralation between Genfit and INGERSOLL
Given the investment horizon of 90 days Genfit is expected to under-perform the INGERSOLL. In addition to that, Genfit is 2.35 times more volatile than INGERSOLL RAND LUXEMBOURG FIN. It trades about -0.1 of its total potential returns per unit of risk. INGERSOLL RAND LUXEMBOURG FIN is currently generating about -0.23 per unit of volatility. If you would invest 9,490 in INGERSOLL RAND LUXEMBOURG FIN on September 22, 2024 and sell it today you would lose (747.00) from holding INGERSOLL RAND LUXEMBOURG FIN or give up 7.87% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 32.81% |
Values | Daily Returns |
Genfit vs. INGERSOLL RAND LUXEMBOURG FIN
Performance |
Timeline |
Genfit |
INGERSOLL RAND LUXEM |
Genfit and INGERSOLL Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Genfit and INGERSOLL
The main advantage of trading using opposite Genfit and INGERSOLL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Genfit position performs unexpectedly, INGERSOLL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in INGERSOLL will offset losses from the drop in INGERSOLL's long position.Genfit vs. HCW Biologics | Genfit vs. Molecular Partners AG | Genfit vs. MediciNova | Genfit vs. Anebulo Pharmaceuticals |
INGERSOLL vs. Apogee Therapeutics, Common | INGERSOLL vs. Abcellera Biologics | INGERSOLL vs. Western Copper and | INGERSOLL vs. Genfit |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Fundamental Analysis View fundamental data based on most recent published financial statements |